|
|
|
Stelazine advertisement, 1961. Mental Hospitals, Vol. 12, No. 2. Stelazine® brand of trifluoperazine should be tried in chronic schizophrenics Clinical evidence shows that 'Stelazine' can produce significant improvement in at least 30%-40% of a given group of chronic schizophrenics. Because of this demonstrated effectiveness, 'Stelazine' should be tried in chronic schizophrenics, no matter how discouraging the results of previous therapies may have been -- no matter whether the patient is hyperactive, withdrawn, or has delusions or hallucinations. And it should be given at high enough dosages for long enough periods of time. Smith, Kline & French Laboratories SK&F leaders in psychopharmaceutical research |